150 related articles for article (PubMed ID: 15316195)
1. Characterization of the DialGuard device for endotoxin removal in hemodialysis.
Szathmary S; Hegyi E; Amoureux MC; Rajapakse N; Chicorka L; Szalai G; Reszegi K; Derbyshire Z; Paluh J; Dodson B; Grandics P
Blood Purif; 2004; 22(5):409-15. PubMed ID: 15316195
[TBL] [Abstract][Full Text] [Related]
2. Ultrafiltration and endotoxin removal from dialysis fluids.
Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
[TBL] [Abstract][Full Text] [Related]
3. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
Bigazzi R; Atti M; Baldari G
Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin.
Pegues DA; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Gordon SM; Favero MS; Jarvis WR
J Am Soc Nephrol; 1992 Oct; 3(4):1002-7. PubMed ID: 1450362
[TBL] [Abstract][Full Text] [Related]
5. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes.
Bender H; Pfläzel A; Saunders N; Czermak P; Catapano G; Vienken J
Artif Organs; 2000 Oct; 24(10):826-9. PubMed ID: 11091173
[TBL] [Abstract][Full Text] [Related]
6. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
Kumano K; Yokota S; Nanbu M; Sakai T
Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
[TBL] [Abstract][Full Text] [Related]
7. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients.
Kwan BC; Chow KM; Ma TK; Cheng PM; Leung CB; Li PK; Szeto CC
Nephron Clin Pract; 2013; 123(3-4):246-53. PubMed ID: 24008429
[TBL] [Abstract][Full Text] [Related]
8. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
[TBL] [Abstract][Full Text] [Related]
10. High-flux dialyzers, backfiltration, and dialysis fluid quality.
Schiffl H
Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability.
Henrie M; Ford C; Andersen M; Stroup E; Diaz-Buxo J; Madsen B; Britt D; Ho CH
Artif Organs; 2008 Sep; 32(9):701-10. PubMed ID: 18684209
[TBL] [Abstract][Full Text] [Related]
12. Ultrapure dialysate for home hemodialysis?
Ouseph R; Ward RA
Adv Chronic Kidney Dis; 2007 Jul; 14(3):256-62. PubMed ID: 17603979
[TBL] [Abstract][Full Text] [Related]
13. Ultrafiltration of dialysis fluid to obtain a sterile solution during hemodialysis.
Bambauer R; Walther J; Jung WK
Blood Purif; 1990; 8(6):309-17. PubMed ID: 2093329
[TBL] [Abstract][Full Text] [Related]
14. Contamination of dialysis water and dialysate. A survey of 30 centers.
Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
[TBL] [Abstract][Full Text] [Related]
15. Easy production of sterile, pyrogen-free dialysate.
Erley CM; von Herrath D; Hartenstein-Koch K; Kutschera D; Amir-Moazami B; Schaefer K
ASAIO Trans; 1988; 34(3):205-7. PubMed ID: 3196509
[TBL] [Abstract][Full Text] [Related]
16. Bacteria and endotoxin removal from bicarbonate dialysis fluids for use in conventional, high-efficiency, and high-flux hemodialysis.
Oliver JC; Bland LA; Oettinger CW; Arduino MJ; Garrard M; Pegues DA; McAllister S; Moone T; Aguero S; Favero MS
Artif Organs; 1992 Apr; 16(2):141-5. PubMed ID: 10078235
[TBL] [Abstract][Full Text] [Related]
17. Effects of dialysis purity on uremic dyslipidemia.
Schiffl H; Lang SM
Ther Apher Dial; 2010 Feb; 14(1):5-11. PubMed ID: 20438514
[TBL] [Abstract][Full Text] [Related]
18. [The level of endotoxins in hemodialysis water and dialysate].
Skarupskiene I; Bumblyte IA; Kuzminskis V
Medicina (Kaunas); 2007; 43 Suppl 1():81-4. PubMed ID: 17551282
[TBL] [Abstract][Full Text] [Related]
19. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin.
Gordon SM; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Favero MS; Jarvis WR
J Am Soc Nephrol; 1992 Mar; 2(9):1436-44. PubMed ID: 1627766
[TBL] [Abstract][Full Text] [Related]
20. Remission of a recurrent carpal tunnel syndrome by a new device of the hemodialysis method in a long-term hemodialysis patient.
Shiota E; Fujinaga M
Clin Nephrol; 2000 Mar; 53(3):230-4. PubMed ID: 10749305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
